Clinical trial Recruiting at 1 site Interventional Ages 18 and up

HFNC During Bronchoscopy for Respiratory Failure

Official title: Role of High Flow Nasal Cannula During Fiber-optic Bronchoscopy in Patients With Respiratory Failure

Run by Mansoura University · NCT07880964 · Data updated 2026-11-12

This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedApril 12, 2026
Main results expectedOctober 2027
Study endsNovember 2027
Registry record updatedOctober 19, 2026
Trial IDNCT07880964 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with respiratory failure who are undergoing clinically indicated fiber-optic bronchoscopy and consent to participate.

Probably not a fit

Patients with immediate intubation needs, severe hypoxemia despite maximal non-invasive support, hemodynamic instability, or contraindications to bronchoscopy or HFNC may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-group study evaluates the safety and potential benefits of high-flow nasal cannula (HFNC) oxygen during fiber-optic bronchoscopy in patients with respiratory failure. HFNC will be started about 10 minutes before the procedure and continued through the bronchoscopy and for 1–2 hours afterward, with oxygen flow adjusted to keep SpO2 near target ranges. The study will monitor oxygenation, ventilation, procedure interruptions, adverse events, patient comfort, and clinical outcomes to determine feasibility and potential improvements over standard care. Patients will receive HFNC via the Vapotherm Precision Flow Hi-VNI system, with FiO2 titrated to maintain SpO2 targets depending on whether they have type 2 respiratory failure. Standard monitoring, including arterial blood gases, will be used to assess safety and response during and after the procedure.

Why it matters

Potential benefit: If successful, HFNC during bronchoscopy could improve oxygenation and reduce complications for patients with respiratory failure undergoing the procedure.

How similar studies have gone: Previous studies in similar settings have explored HFNC during procedures with mixed but encouraging signals for safety and tolerability.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants will be eligible for inclusion if they meet all of the following criteria:

1. Adult patients undergoing clinically indicated fiber-optic bronchoscopy.
2. Patients with respiratory failure requiring supplemental oxygen or respiratory support.
3. Patients who provide written informed consent to participate in the study.

Exclusion Criteria:

* Participants will be excluded if they meet any of the following criteria:

  1. Patients requiring immediate endotracheal intubation or invasive mechanical ventilation before bronchoscopy.
  2. Patients with severe or refractory hypoxemia despite maximal non-invasive oxygen/respiratory support before the procedure.
  3. Hemodynamic instability that precludes safe fiber-optic bronchoscopy.
  4. Patients with contraindications to fiber-optic bronchoscopy or to the planned bronchoscopy procedure.
  5. Patients who refuse or withdraw informed consent.
  6. Patients in whom HFNC cannot be safely applied or tolerated.

Where it's running

  • Faculty of Medicine, Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.